Zyus Life Sciences Corporation (ZYUS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,902 | 3,978 | 212 |
| Marketable Securities | 0 | 1,874 | N/A |
| Receivables | 366 | 627 | 243 |
| Inventories | 630 | 2,042 | 4,202 |
| Other current assets | 189 | 867 | 1,609 |
| TOTAL | $3,362 | $9,388 | $6,266 |
| Non-Current Assets | |||
| PPE Net | 11,159 | 13,894 | 17,032 |
| Intangibles | 0 | 18,193 | 41,259 |
| Other Non-Current Assets | 152 | 152 | 156 |
| TOTAL | $11,311 | $32,239 | $58,447 |
| Total Assets | $14,673 | $41,627 | $64,712 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 9,118 | 6,149 | 899 |
| Accounts payable and accrued liabilities | 4,483 | 3,435 | 8,512 |
| Accrued Expenses | 3,374 | 3,256 | 4,526 |
| TOTAL | $17,381 | $13,244 | $14,268 |
| Non-Current Liabilities | |||
| Long Term Debt | 371 | 637 | 30,799 |
| Other Non-Current Liabilities | 0 | 0 | 3,976 |
| TOTAL | $2,636 | $5,269 | $45,703 |
| Total Liabilities | $20,017 | $18,513 | $59,971 |
| Shareholders' Equity | |||
| Common Shares | 156,699 | 154,088 | 92,673 |
| Retained earnings | -173,992 | -140,187 | -97,596 |
| Other shareholders' equity | 2,740 | 3,820 | 4,035 |
| TOTAL | $-5,344 | $23,114 | $4,741 |
| Total Liabilities And Equity | $14,673 | $41,627 | $64,712 |